The HMZ 2.0 intervention, sponsored by Penn State University, aims to address the growing concern of gestational weight gain (GWG) among pregnant women with overweight and obesity. With an estimated 144 participants, the trial seeks to validate a digital platform that personalizes weight management strategies, potentially leading to improved maternal and infant health outcomes. The intervention's focus on behavioral modification through technology positions it favorably in the expanding digital health market, particularly in maternal health. As the prevalence of obesity during pregnancy rises, successful outcomes could enhance market penetration and attract partnerships with healthcare providers and payers. The competitive landscape includes traditional prenatal care and emerging digital health solutions, necessitating a robust demonstration of efficacy and usability to differentiate from existing offerings.